Literature DB >> 21070534

Prevalence and outcome of litigation claims in England after laparoscopic cholecystectomy.

J A Gossage1, M J Forshaw.   

Abstract

BACKGROUND: Approximately, 50,000 cholecystectomies are performed annually in the United Kingdom resulting in a number of negligence claims referred to the NHS Litigation Authority (NHSLA). The aim of this study was to assess the prevalence and outcomes of claims reported to the NHSLA after laparoscopic cholecystectomy performed in England between 1995 and 2008.
METHODS: Data were requested from the NHSLA on all claims related to laparoscopic cholecystectomy which occurred in England between 1995 and 2008.
RESULTS: A review of the data provided by the NHSLA data identified over 300 claims in this time period. Of the claims identified, 244 have been completed. Common bile duct injury (41%), bile leak (12%), bowel injury (9%), haemorrhage (9%) and fatality (9%) were the most frequent types of claim. Common bile duct injury resulted in the highest proportion of successful claims (86%) and the largest sums paid to the claimant (average £65,000). DISCUSSION: Common bile duct injury is the most common claim to the NHSLA after laparoscopic cholecystectomy and results in the highest proportion of successful claims and the largest sums paid to the claimant.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21070534     DOI: 10.1111/j.1742-1241.2009.02200.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  10 in total

1.  The retrospective documentation of legal cases with bile duct injury that were submitted for consideration to İstanbul Forensic Medicine Institute by the courts between 2008-2012.

Authors:  M Arif Karakaya; Okay Koç; Feza Ekiz; A Feran Ağaçhan
Journal:  Ulus Cerrahi Derg       Date:  2014-12-01

2.  Causes and costs of a decade of litigation following emergency appendectomy in England.

Authors:  Thomas Mosedale; Dmitri Nepogodiev; J Edward F Fitzgerald; Aneel Bhangu
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

3.  Bile duct injury repair —— earlier is not better.

Authors:  Vinay K Kapoor
Journal:  Front Med       Date:  2015-12       Impact factor: 4.592

4.  Real-time near-infrared (NIR) fluorescent cholangiography in single-site robotic cholecystectomy (SSRC): a single-institutional prospective study.

Authors:  Giuseppe Spinoglio; Fabio Priora; Paolo Pietro Bianchi; Francesco Saverio Lucido; Alessio Licciardello; Valeria Maglione; Federica Grosso; Raul Quarati; Ferruccio Ravazzoni; Luca Matteo Lenti
Journal:  Surg Endosc       Date:  2012-12-28       Impact factor: 4.584

5.  Is routine intraoperative cholangiogram necessary in the twenty-first century? A national view.

Authors:  Elizaveta Ragulin-Coyne; Elan R Witkowski; Zeling Chau; Sing Chau Ng; Heena P Santry; Mark P Callery; Shimul A Shah; Jennifer F Tseng
Journal:  J Gastrointest Surg       Date:  2013-01-05       Impact factor: 3.452

6.  Treatment and surveillance of polypoid lesions of the gallbladder in the United Kingdom.

Authors:  Gabriele Marangoni; Abdul Hakeem; Giles J Toogood; J Peter A Lodge; K Raj Prasad
Journal:  HPB (Oxford)       Date:  2012-05-11       Impact factor: 3.647

7.  Asymptomatic Gallstones (AsGS) - To Treat or Not to?

Authors:  Anu Behari; V K Kapoor
Journal:  Indian J Surg       Date:  2011-12-03       Impact factor: 0.656

8.  Biliary complications postlaparoscopic cholecystectomy: mechanism, preventive measures, and approach to management: a review.

Authors:  Norman Oneil Machado
Journal:  Diagn Ther Endosc       Date:  2011-06-12

9.  Medico-legal aspects of bile duct injury.

Authors:  Vinay Kumar Kapoor
Journal:  J Minim Access Surg       Date:  2016 Jan-Mar       Impact factor: 1.407

10.  Evaluation of postoperative analgesia of erector spinae plane block in elective laparoscopic cholecystectomy: a randomized controlled trial.

Authors:  Divya Sethi; Garima Garg
Journal:  Turk J Anaesthesiol Reanim       Date:  2021-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.